Medprin Regenerative Medical Technologies Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 227.54 million compared to CNY 195.02 million a year ago. Revenue was CNY 230.87 million compared to CNY 195.25 million a year ago.

Net income was CNY 40.88 million compared to CNY 35.89 million a year ago. Basic earnings per share from continuing operations was CNY 0.62 compared to CNY 0.54 a year ago. Diluted earnings per share from continuing operations was CNY 0.62 compared to CNY 0.54 a year ago.